biotech

UCSF Recruits Smokers For NicVax Trials

Filed in archive Drugs, Vaccines and Therapeutics on June 13, 2006

UCSF Recruits Smokers For NicVax Trials
Earlier this year, Nabi Pharmaceuticals' NicVax received a fast-track designation by the Food and Drug Administration to speed up the development of the investigational vaccine against nicotine addiction. NicVax acts by binding to and preventing the entry of nicotine into the brain, thereby reducing the addictive effects of smoking.

The University of California San Francisco's Habit Abatement Clinic is now recruiting smokers to determine whether the vaccine can help people quit smoking and avoid a relapse within 12 months. Participation in the study requires a one-year commitment. The study will be sponsored by Nabi Pharmaceuticals and the National Institute on Drug Abuse.


Permalink: UCSF Recruits Smokers For NicVax Trials

Tags: smoking  vaccine  biotech  nicvax  smokers  ucsf+recruits  nicvax+trials  smokers+nicvax 

Vote for UCSF Recruits Smokers For NicVax Trials:

  • Currently 9.60/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 9.60 out of 5 vote(s) cast.
 
Share It
RSSrss
Google google
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Tagcloud
Most Popular   Best of   Biotech Hubs and Facilities   Biotech/Science Blogs   Corporate and Industrial News   Diagnostics, Methodologies and Instrumentation   Did you know   Drugs, Vaccines and Therapeutics   Energy, Environment and Ecology   Food and Agriculture   Gene Therapy   Genomics, Proteomics and Bioinformatics   Information About   Meetings and Other Events   Microbiology   Misc   Nanomedicine   Other Biotechnology News   Patents and Intellectual Property Rights   Quick introduction   Stem Cells